Interferons in MS Treatment: report from the Canadian MS Forum symposium, 26-29 August 2004, Québec, Canada.
The epidemiology of MS in Newfoundland and Labrador was one of the topics discussed at the first Canadian MS Forum symposium, held in St John's, Newfoundland, Canada. Also discussed were the benefits of neuroprotection and neuroregeneration in MS, and diagnosis using the McDonald criteria. The efficacy of interferon beta-1b treatment and evidence on new disease hypotheses were reviewed. Latest news on the growing success and reach of the MS Forum was also presented, with the aim of providing a link between MS experts and institutions.
Duquette
Pierre
P
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D006801:Humans; D000068576:Interferon beta-1b; D016899:Interferon-beta / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy*
D000276:Adjuvants, Immunologic; D000068576:Interferon beta-1b; D016899:Interferon-beta